Carregant...
Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro
BACKGROUND AND PURPOSE: There is significant variation in individual response to opioid drugs, which may result in inappropriate opioid therapy. Polymorphisms of the μ opioid receptor (MOP receptor) may contribute to individual variation in opioid response by affecting receptor function, and the eff...
Guardat en:
| Publicat a: | Br J Pharmacol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Blackwell Publishing Ltd
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4241093/ https://ncbi.nlm.nih.gov/pubmed/24846673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.12785 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|